论文部分内容阅读
ＣＹＦＲＡ２１ -１是近年应用于临床的肿瘤标记物 ,在上皮组织来源的肿瘤中常有过量表达［１］;本文通过对１０４例鼻咽癌患者及２７例鼻咽恶性淋巴瘤患者ＣＹＦＲＡ２１ -１的血清学检测以探讨其对鼻咽癌和鼻咽恶性淋巴瘤的鉴别作用。资料和方法一、临床资料 :鼻咽癌组共１０
CYFRA21 -1 is a tumor marker used clinically in recent years and is often overexpressed in epithelial-derived tumors [1]. In this study, CYFRA21 -1 serum was obtained from 104 patients with nasopharyngeal carcinoma and 27 patients with nasopharyngeal malignant lymphoma Test to explore its differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma. Materials and Methods First, the clinical data: a total of 10 nasopharyngeal carcinoma group